文献速递神经眼科眼整形与眼眶

分次适形放疗治疗原发性视神经鞘脑膜瘤的长期疗效

Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.
PubMed 文献 · Br J Ophthalmol · 2018-12-20

本研究回顾性分析四个学术医疗中心1995至2007年间接受分次适形放疗(FCRT)的原发性视神经鞘脑膜瘤(ONSM)成人患者,随访至少10年。16例患者平均随访14.6年,末次随访时88%视力改善或稳定,69%保留或达到≥20/40,自动视野平均偏差稳定,2例出现放射性视网膜病变。FCRT可稳定或改善视功能,显著眼部后遗症风险低,对于因视感觉和/或眼运动功能丧失而需要干预的原发性ONSM患者,应考虑替代手术治疗。

要点

  • FCRT治疗后88%患者视力改善或稳定,69%保留或达到≥20/40。
  • 自动视野平均偏差治疗前-14.5 dB与末次随访-12.2 dB相比稳定(p=0.68,n=10)。
  • 2例(13%)发生放射性视网膜病变,其中1例视力较治疗前更差。

核心结论

  • FCRT可稳定或改善原发性ONSM患者的视功能,且显著眼部后遗症风险低。
  • 对于因视感觉和/或眼运动功能丧失而需要干预的原发性ONSM患者,应考虑FCRT而非手术。

研究设计与样本

  • 回顾性病历审查并前瞻性随访,纳入四个学术医疗中心1995至2007年间接受FCRT的原发性ONSM成人患者,随访≥10年。
  • 共识别16例患者,平均治疗后随访14.6年(范围10.5-20.7年)。

主要发现

  • 末次随访时16例中14例(88%)视力改善或稳定,11例(69%)保留或达到≥20/40。
  • 自动视野平均偏差保持稳定:治疗前-14.5 dB,末次随访-12.2 dB(p=0.68,n=10)。
  • 2例(11%)有持续疼痛、突眼或复视,治疗前为6例(38%)(p=0.11)。
  • 2例(13%)在治疗完成后超过6个月发生放射性视网膜病变,其中1例(50%)视力较治疗前更差。
  • 无患者出现对侧眼肿瘤累及或放射性损伤。

临床怎么用

  • 对于因视感觉和/或眼运动功能丧失而需要干预的原发性ONSM患者,可考虑FCRT替代手术。
  • FCRT后需长期随访,关注放射性视网膜病变等迟发并发症。

局限性

  • 回顾性设计,样本量小(16例),来自四个中心。
  • 部分分析样本量更小(如视野分析n=10)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIM: Fractionated conformal radiotherapy (FCRT) is now used to treat vision-threatening optic nerve sheath meningioma (ONSM), but long-term efficacy and safety data are lacking; the purpose of this study was to assess these key data. METHODS: This is a retrospective chart review with prospective follow-up of adult patients treated with FCRT for primary ONSM at four academic medical centres between 1995 and 2007 with ≥10 years of follow-up after treatment. RESULTS: 16 patients were identified with a mean post-treatment follow-up of 14.6 years (range: 10.5-20.7 years). The mean age at symptom onset was 47.6 years (range: 36-60 years). FCRT was performed at a mean of 2.3 years after symptom onset (range: 0.2-14.0 years). At last follow-up, visual acuity had improved or stabilised in 14 of the 16 (88%) patients, and 11 (69%) had retained or achieved ≥20/40. The mean deviation on automated perimetry remained stable (-14.5 dB pretreatment vs -12.2 dB at last follow-up; p=0.68, n=10). Two (11%) patients had persistent pain, proptosis or diplopia, compared with six (38%) pretreatment (p=0.11). Two (13%) patients developed radiation retinopathy more than 6 months after completion of therapy, one (50%) of whom had worse visual acuity compared with pretreatment. No patient developed tumour involvement or radiation damage in the fellow eye. CONCLUSION: FCRT stabilises or improves visual function in patients with primary ONSM and is associated with a low risk of significant ocular sequelae. This treatment should be considered instead of surgery in patients with primary ONSM who require intervention due to loss of visual sensory and/or ocular motor function.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pandit R, Paris L, Rudich DS, et al. Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma. Br J Ophthalmol. 2018. PMID: 30573496. doi:10.1136/bjophthalmol-2018-313135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。